Retraction
miR-4295 promotes cell proliferation and invasion in anaplastic thyroid carcinoma via CDKN1A
Paper Information
Record ID:
19915
Publication Date:
July 29, 2015
Retraction Date:
January 01, 2019
(6.9 years years ago)
Subjects:
Institutions:
- Oncology Department, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Laboratory of Tumor Biology, Zhengzhou University, Zhengzhou, China
- Gastrointestinal Surgery Department, People's Hospital of Zhengzhou, Zhengzhou, China
- Liver Transplantation Hepatobiliary Surgery Department, People's Hospital of Zhengzhou, Zhengzhou, China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Elsevier
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1016/j.bbrc.2018.11.198Additional Notes:
date of retraction unknown, html page overwrite, date estimated from notifications; separate notice issued later, on 6/22/2019;
Citations (25)
25
Total Citations10
Post-Retraction(40.0%)
15
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
8
Within 1 year
1
After 2+ years
1155
Days since retraction (latest)
Paper citing miR-4295 promotes cell proliferation and invasion ...
Unknown Authors
Unknown Journal
Published: Mar 2022
1155 days after retraction
miR‑106b‑5p promotes cell proliferation and cell cycle progression by directly targeting CDKN1A in osteosarcoma
Chuan He, Hongwei Chen, Yan Liu et al. (7 authors)
Experimental and Therapeutic Medicine
Open Access
Published: Mar 2020
14 citations
14 citations
430 days after retraction
Paper citing miR-367 promotes proliferation and invasion of hep...
Unknown Authors
Unknown Journal
Published: Aug 2019
212 days after retraction
Paper citing miR-4295 promotes cell proliferation and invasion ...
Unknown Authors
Unknown Journal
Published: Aug 2019
212 days after retraction
Paper citing miR-367 promotes proliferation and invasion of hep...
Unknown Authors
Unknown Journal
Published: Aug 2019
212 days after retraction
Paper citing miR-367 promotes proliferation and invasion of hep...
Unknown Authors
Unknown Journal
Published: Aug 2019
212 days after retraction
Retraction notice to “The miR-599 promotes non-small cell lung cancer cell invasion via SATB2” [Biochem. Biophys. Res. Commun. 485/1 (2017) 35–40]
Wenjun Tian, Guanghai Wang, Yiqing Liu et al. (13 authors)
Biochemical and Biophysical Research Communications
Published: Jun 2019
1 citation
1 citation
172 days after retraction
MiR-4295 facilitates cell proliferation and metastasis in head and neck squamous cell carcinoma by targeting NPTX1
Shun Lu, Cheng Zhou, Bingwen Zou et al. (5 authors)
Genes and Immunity
Published: May 2019
23 citations
23 citations
141 days after retraction
Paper citing miR-4295 promotes cell proliferation and invasion ...
Unknown Authors
Unknown Journal
Published: Feb 2019
31 days after retraction
miR‑544 inhibits the migration and invasion of anaplastic thyroid cancer by targeting Yin Yang‑1
Feng Wang, Zhiqiang Li, Bo Sun
Oncology Letters
Open Access
Published: Jan 2019
13 citations
13 citations
8 days after retraction
Paper citing miR-4295 promotes cell proliferation and invasion ...
Unknown Authors
Unknown Journal
Published: Oct 2018
65 days before retraction
Downregulation of microRNA-4295 enhances cisplatin-induced gastric cancer cell apoptosis through the EGFR/PI3K/Akt signaling pathway by targeting LRIG1
Rong Yan, Kang Li, Dawei Yuan et al. (7 authors)
International Journal of Oncology
Open Access
Published: Oct 2018
33 citations
33 citations
81 days before retraction
Paper citing miR-4295 promotes cell proliferation and invasion ...
Unknown Authors
Unknown Journal
Published: Sep 2018
100 days before retraction
Paper citing miR-4295 promotes cell proliferation and invasion ...
Unknown Authors
Unknown Journal
Published: Jul 2018
184 days before retraction
Paper citing miR-4295 promotes cell proliferation and invasion ...
Unknown Authors
Unknown Journal
Published: Feb 2018
316 days before retraction
Paper citing miR-4295 promotes cell proliferation and invasion ...
Unknown Authors
Unknown Journal
Published: Feb 2018
334 days before retraction
Unveiling massive numbers of cancer-related urinary-microRNA candidates via nanowires
Takao Yasui, Takeshi Yanagida, Satoru Ito et al. (18 authors)
Science Advances
Open Access
Published: Dec 2017
208 citations
208 citations
396 days before retraction
miR-130a Deregulates PTEN and Stimulates Tumor Growth
Huijun Wei, Ri Cui, Julian Bahr et al. (8 authors)
Cancer Research
Open Access
Published: Sep 2017
58 citations
58 citations
466 days before retraction
The role of microRNAs in different types of thyroid carcinoma: a comprehensive analysis to find new miRNA supplementary therapies
Shaghayegh Pishkari, Mahdi Paryan, Mehrdad Hashemi et al. (5 authors)
Journal of Endocrinological Investigation
Published: Jul 2017
68 citations
68 citations
519 days before retraction
Paper citing miR-4295 promotes cell proliferation and invasion ...
Unknown Authors
Unknown Journal
Published: Mar 2017
643 days before retraction
Paper citing miR-200 Regulates Epithelial–Mesenchymal Transitio...
Unknown Authors
Unknown Journal
Published: Feb 2017
699 days before retraction
Expression of MicroRNAs in Thyroid Carcinoma
Gaohong Zhu, Lijun Xie, Daniel Miller
Methods in molecular biology
Published: Jan 2017
18 citations
18 citations
730 days before retraction
Epigenetic modulators of thyroid cancer
Sandra Rodríguez‐Rodero, Elías Delgado, Lucía Díaz-Naya et al. (5 authors)
Endocrinología Diabetes y Nutrición (English ed )
Published: Jan 2017
2 citations
2 citations
730 days before retraction
Epigenetic modulators of thyroid cancer
Sandra Rodríguez‐Rodero, Elías Delgado, Lucía Díaz-Naya et al. (5 authors)
Endocrinología Diabetes y Nutrición
Published: Jan 2017
25 citations
25 citations
730 days before retraction
Paper citing miR-4295 promotes cell proliferation and invasion ...
Unknown Authors
Unknown Journal
Published: Mar 2016
1036 days before retraction
Quick Stats
Total Citations:
25
Years Since Retraction:
6.9 years
Open Access:
Yes
Last Checked:
Never